New TNM staging system for nasopharyngeal cancer at ESMO Asia
Herbert Loong, Associate Professor in the Department of Clinical Oncology at The Chinese University of Hong Kong, reshared the post on LinkedIn by Pierre Blanchard, Radiation Oncology Clinical section chief at Gustave Roussy Cancer Institute, adding:
“Great to see my mentor Brigette Ma of CUHK Medicine and The Chinese University of Hong Kong – CUHK discussing this important advancement in staging for NPC patients with Melvin LK CHUA.”
Quoting Pierre Blanchard’s post:
“Professor Brigette Ma discussing the new TNM staging system for nasopharyngeal cancer at ESMO Asia.”
Herbert H. F. Loong is the Chair-Elect of the International Affairs Committee, a Scientific Track Member (2022-2024), and the Track Leader for Sarcoma (2023) at the American Society of Clinical Oncology (ASCO). Additionally, he has been promoted to Steering Committee Member at the Lung Cancer Policy Network. Dr. Loong is also the Chairperson of the Asia Pacific Coalition against Lung Cancer, a Board Member of the Connective Tissue Oncology Society, and a Committee Member of the International Association for the Study of Lung Cancer. He is an Associate Professor in the Department of Clinical Oncology at The Chinese University of Hong Kong (CUHK).
More posts featuring Herbert Loong.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023